Caricamento...

Bleeding complications associated with glycoprotein IIb/IIIa inhibitors in patients 80 years of age and older undergoing percutaneous coronary intervention

BACKGROUND: Treatment of symptomatic coronary artery disease with percutaneous intervention requires antithrombotic therapy. Patients with elevated thromboembolic risk benefit from therapy with glycoprotein IIb/IIIa inhibitors. The safety and effectiveness of glycoprotein IIb/IIIa inhibition have be...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Germing, Alfried, Bojara, Waldemar, Lawo, Thomas, Ewers, Aydan, Grewe, Peter, Mügge, Andreas, Lindstaedt, Michael
Natura: Artigo
Lingua:Inglês
Pubblicazione: Pulsus Group Inc 2010
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2954030/
https://ncbi.nlm.nih.gov/pubmed/20959881
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !